Biotech Stocks: Safe vs Sexy

Do you want safe, or sexy? That’s the question facing biotechnology investors, according to a recent research note from Cowen analysts that previews the sector’s second-quarter financial results. “In heady times, large cap provides a safe haven, smid caps the sex appeal,” reads the note. After shrugging off a selloff in late June, the Nasdaq [...]
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.